Advertisement

Topics

M&As this week: BriaCell Therapeutics, Lentigen Technology

19:00 EDT 27 Jul 2017 | Net Resources International

BriaCell Therapeutics plans to acquire Sapientia Pharmaceuticals through its subsidiary BriaCell Therapeutics (BriaCell USA).

Original Article: M&As this week: BriaCell Therapeutics, Lentigen Technology

NEXT ARTICLE

More From BioPortfolio on "M&As this week: BriaCell Therapeutics, Lentigen Technology"

Quick Search
Advertisement